Index. Note: Page numbers of article titles are in boldface type.

Size: px
Start display at page:

Download "Index. Note: Page numbers of article titles are in boldface type."

Transcription

1 Note: Page numbers of article titles are in boldface type. A Acute lymphoblastic leukemia, in India, pediatric, global approach to, core resources in low- and middle-income countries, 423 future directions, incidence, 420 treatment and outcomes, Acute myelogenous leukemia, in India, pediatric, global approach to, 424 Acute promyelocytic leukemia, in China and Hong Kong, revolution in treatment of, all-trans retinoic acid, arsenic trioxide, Africa, sub-saharan, hematology in, blood transfusions in, , bone marrow depression or aplasia, hemostasis and thrombosis, anticoagulation therapy, 469 coagulopathies, hemophilia, 470 low prothrombin and vitamin K-dependent coagulation factors, snake bite, 469 thromboembolic disease, 469 von Willebrand disease, 470 platelet disorders, 468 vascular purpura, 468 red cell disorders, anemia, hyperreactive malarial splenomegaly, 461 in pregnancy, inherited red cell disorders, iron deficiency anemia, 461 malaria causing anemia, nutritional anemia, sickle cell disease in, , bottlenecks in care of, causes of death in children with, bacteremia, malaria, future of, 349 future priorities for, 351 natural history of, 346 Hematol Oncol Clin N Am 30 (2016) hemonc.theclinics.com /16/$ see front matter ª 2016 Elsevier Inc. All rights reserved.

2 514 Africa (continued ) origins of sickle mutation, present and future global burden, specific treatments in, African trypanosomiasis, hematologic changes associated with, All-trans retinoic acid (ATRA), for acute promyelocytic leukemia treatment in China and Hong Kong, American trypanosomiasis, hematologic changes associated with, 408 Anemia, estimating the global burden of, methods, results, summary and discussion, hemolytic, related to G6PD deficiency and, in India, nutritional, 434 other, 435 in sub-saharan Africa, iron deficiency, 461 malaria and, nutritional, folate deficiency, 465 iron deficiency, 464 vitamin B 12 deficiency, 465 pregnancy and, iron deficiency, diagnosis and prevention at the population level, malarial, prevalence and multiple causes in the developing world, Anthelmintic therapy, in prevention and control of anemia, 314 Anticoagulation therapy, in sub-saharan Africa, 469 Aplasia, in sub-saharan Africa, Aplastic anemia, geographic variability in distribution and expression of, 242 Arsenic trioxide, for acute promyelocytic leukemia treatment in China and Hong Kong, Asia, control and management of thalassemias in, global issues, in other regions of, Thailand, B Bacteremia, in children with sickle cell disease in sub-saharan Africa, Bartonellosis, hematologic changes associated with, Blood disorders. See Hematologic disorders. Blood transfusion, hematology practice and, in sub-saharan Africa, in developing countries, blood-borne infections, improvements, developing national transfusion service in Nigeria, Ebola pandemic in West Africa, 488 in blood supply, in clinical use of blood,

3 515 in screening for blood-transmitted infections, 486 meeting financial requirements of transfusion services, 486 putting WHO objectives into practice, 484 research in transfusion medicine, safety and supply, 478 supply and usage, blood donors, focus on sub-saharan Africa, systems, 483 use of blood products, testing blood products, 480 Bone marrow depression, in sub-saharan Africa, Bone marrow response, defective, associated with severe malaria, Burden of disease, global, of anemia, global, of inherited disorders of hemoglobin, C Capacity building, in global approach to pediatric hematologic malignancies, 419 Chagas disease, hematologic changes associated with, 408 Children. See also Pediatrics. HIV in, in developing countries, hematologic changes associated with, risks of iron supplementation in, clinical trials data, diarrhea, infection, 315 malaria, China, hematological practice in Hong Kong and, burden of hematological disease in, 446 developing strategies, 453 genetic hematologic disorders in, glucose-6-phosphate dehydrogenase deficiency, 449 hemophilias, thalassesmias, haploidentical allogeneic hematopoietic stem cell transplantation in, 453 health care systems in, 446 malignant hematologic diseases in, acute promyelocytic leukemia, different patterns of lymphomas, 449 natural killer/t-cell lymphomas, other T-cell lymphoid malignancies, 451 Chronic kidney disease, estimating global burden of anemia due to, Chronic lymphocytic leukemia, in sub-saharan Africa, 467 Chronic myelogenous leukemia, pediatric, global approach to, 425 Chronic myeloid leukemia, in sub-saharan Africa, 467 Coagulation disorders, associated with severe malaria, 403 in sub-saharan Africa, inherited disorders, in India, 436 Consanguinity, effect on health burden of inherited disorders of hemoglobin, 332

4 516 D Dengue, in the tropics, hemostatic failure in, Developing countries. See also specific countries and regions. blood transfusion in, blood-borne infections, improvements, developing national transfusion service in Nigeria, Ebola pandemic in West Africa, 488 in blood supply, in clinical use of blood, in screening for blood-transmitted infections, 486 meeting financial requirements of transfusion services, 486 putting WHO objectives into practice, 484 research in transfusion medicine, safety and supply, 478 supply and usage, blood donors, focus on sub-saharan Africa, systems, 483 use of blood products, testing blood products, 480 challenges and complexity of blood disorders in, anemia, prevalence and multiple causes of, geographic variability in hematologic diseases, aplastic anemia, 242 disorders unique to certain countries, 242, 243 hereditary blood disorders, 242 lymphoma and leukemia, hemostatic failure as manifestation of systemic disease in the tropics, dengue, other viral hemorrhagic fevers, 241 infections in the tropics, hematologic changes associated with, childhood HIV, hookworm, 237 malaria, 236 schistosomiasis, 237 trypanosomiasis, 237 visceral leishmaniasis (Kala-azar), 237 malabsorption in the tropics, hematologic aspects of, tropical eosinophilia, 238 Diarrhea, increased risk of, with iron supplementation, E Ebola virus, immunity in West African survivors of, 488 Eosinophilia, tropical, 238 Epidemiologic transition theory, effect on health burden of inherited disorders of hemoglobin, 333 Erythrocytes, decreased deformability, in severe malaria, 400

5 517 F Favism, G6PD deficiency hemolytic anemia, due to glucose-6-phosphate dehydrogenase (G6PD) deficiency, Favism. See Glucose-6-phosphate dehydrogenase (G6PD) deficiency. Ferritin, for iron status measurement at population level, Fevers, viral hemorrhagic in the tropics, hemostatic failure in, dengue, others, 241 Folate deficiency, anemia due to, in sub-saharan Africa, 465 G Gastrointestinal conditions, estimating global burden of anemia due to, Geographic variability, in distribution and expression of hematologic diseases, aplastic anemia, 242 disorders unique to certain countries, 242, 243 hereditary blood disorders, 242 lymphoma and leukemia, Global hematology, anemia, global burden of, methods, results, summary and discussion, blood transfusion in developing countries, blood-borne infections, improvements, developing national transfusion service in Nigeria, Ebola pandemic in West Africa, 488 in blood supply, in clinical use of blood, in screening for blood-transmitted infections, 486 meeting financial requirements of transfusion services, 486 putting WHO objectives into practice, 484 research in transfusion medicine, safety and supply, 478 supply and usage, blood donors, focus on sub-saharan Africa, systems, 483 use of blood products, testing blood products, 480 complexity and challenges in developing countries, anemia, prevalence and multiple causes of, geographic variability in hematologic diseases, aplastic anemia, 242 disorders unique to certain countries, 242, 243 hereditary blood disorders, 242 lymphoma and leukemia, hemostatic failure as manifestation of systemic disease in the tropics, dengue,

6 518 Global (continued) other viral hemorrhagic fevers, 241 infections in the tropics, hematologic changes associated with, childhood HIV, hookworm, 237 malaria, 236 schistosomiasis, 237 trypanosomiasis, 237 visceral leishmaniasis (Kala-azar), 237 malabsorption in the tropics, hematologic aspects of, tropical eosinophilia, 238 glucose-6-phosphate dehydrogenase deficiency (G6PD), animal models and drug screening, biochemistry of, clinical manifestations of, epidemiology and malaria selection, evolution, management of, 384 molecular-genetic basis of, testing for, and malaria control, hematologic changes due to infections in the tropics, bartonellosis, hookworm, malaria, clinical management of, hyperreactive malarial splenomegaly syndromes, in pregnancy, in splenectomized patients, 404 severe, schistosomiasis, 407 trypanosomiasis, visceral leishmaniasis (Kala-azar), in Hong Kong and China, burden of hematological disease in, 446 developing strategies, 453 genetic hematologic disorders in, glucose-6-phosphate dehydrogenase deficiency, 449 hemophilias, thalassesmias, haploidentical allogeneic hematopoietic stem cell transplantation in, 453 health care systems in, 446 malignant hematologic diseases in, acute promyelocytic leukemia, different patterns of lymphomas, 449 natural killer/t-cell lymphomas, other T-cell lymphoid malignancies, 451 in India, disorders of hemostasis and coagulation, inherited coagulation disorders, 436 qualitative disorders of platelets, thrombotic disorders, 436

7 disorders of red cells, hereditary hemochromatosis, 435 nutritional anemias, 434 other anemias, 435 thalassemias and hemoglobinopathies, 435 hematologic malignancies, acute leukemias, lymphoproliferative neoplasms, multiple myeloma, 440 myeloproliferative disorders, in sub-saharan Africa, blood transfusion, bone marrow depression or aplasia, hemostasis and thrombosis, anticoagulation therapy, 469 coagulopathies, hemophilia, 470 low prothrombin and vitamin K-dependent coagulation factors, snake bite, 469 thromboembolic disease, 469 von Willebrand disease, 470 platelet disorders, 468 vascular purpura, 468 red cell disorders, anemia, hyperreactive malarial splenomegaly, 461 in pregnancy, inherited red cell disorders, iron deficiency anemia, 461 malaria causing anemia, nutritional anemia, sickle cell disease, white blood cell disorders, adult T-cell leukemia and lymphoma, chronic lymphocytic leukemia, 467 chronic myeloid leukemia, 467 malignant, inherited disorders of hemoglobin, awareness and recognition of global health burden, current health burden, factors affecting health burden of, future health burden, structural hemoglobin variants, thalassemias, iron deficiency anemia, epidemiology, framework for control, measurement of iron status in public health context, other measures for control, making improvements in resource-limited settings, clinical services,

8 520 Global (continued) expansion of medical education, improved delivery of care, laboratory services, steps to implement quality improvement, pediatric hematologic malignancies, acute lymphoblastic leukemia, acute myelogenous leukemia, 424 capacity building through twinning, 419 chronic myelogenous leukemia, 425 Hodgkin lymphoma, non-hodgkin lymphoma, role of essential medicines, sickle cell disease in sub-saharan Africa, bottlenecks in care of, causes of death in children with, bacteremia, malaria, future of, 349 future priorities for, 351 natural history of, 346 origins of sickle mutation, specific treatments in, thalassemias, global issues, in other regions of Asia, in Thailand, Glucose-6-phosphate dehydrogenase deficiency (G6PD), animal models and drug screening, biochemistry of, clinical manifestations of, epidemiology and malaria selection, evolution, in China and Hong Kong, management of, 384 molecular-genetic basis of, testing for, and malaria control, Gynecologic conditions, estimating global burden of anemia due to, H Hematologic disorders. See also Global hematology and specific disorders. challenges and complexity of, in developing countries, anemia, prevalence and multiple causes of, geographic variability in hematologic diseases, aplastic anemia, 242 disorders unique to certain countries, 242, 243 hereditary blood disorders, 242 lymphoma and leukemia, hemostatic failure as manifestation of systemic disease in the tropics, dengue,

9 other viral hemorrhagic fevers, 241 infections in the tropics, hematologic changes associated with, childhood HIV, hookworm, 237 malaria, 236 schistosomiasis, 237 trypanosomiasis, 237 visceral leishmaniasis (Kala-azar), 237 malabsorption in the tropics, hematologic aspects of, tropical eosinophilia, 238 Hematologic malignancies, in China and Hong Kong, acute promyelocytic leukemia, different patterns of lymphomas, 449 natural killer/t-cell lymphomas, other T-cell lymphoid malignancies, 451 in India, acute leukemias, lymphoproliferative neoplasms, multiple myeloma, 440 myeloproliferative disorders, pediatric, global approach to, acute lymphoblastic leukemia, acute myelogenous leukemia, 424 capacity building through twinning, 419 chronic myelogenous leukemia, 425 Hodgkin lymphoma, non-hodgkin lymphoma, role of essential medicines, Hemochromatosis, hereditary, in India, 435 Hemoglobin, global burden of inherited disorders of, awareness and recognition of global health burden, current health burden, factors affecting health burden of, future health burden, structural hemoglobin variants, thalassemias, Hemoglobinopathies, estimating global burden of anemia due to, in India, 435 Hemolysis, associated with severe malaria, 398, immune complex-mediated, massive intravascular, 400 role of, 398 Hemolytic anemia, due to glucose-6-phosphate dehydrogenase (G6PD) deficiency, Hemophilias, in China and Hong Kong, in sub-saharan Africa, 470 Hemorrhagic fevers, in the tropics, hemostatic failure in viral, dengue, others, 241 Hemostasis, qualitative disorders of, in India, Hereditary blood disorders, geographic variability in distribution and expression of, 242 hemochromatosis, in India,

10 522 Hodgkin lymphoma, pediatric, global approach to, Hong Kong, hematological practice in China and, Hookworm, hematologic changes associated with, 237, Human immunodeficiency virus (HIV), childhood, in developing countries, hematologic changes associated with, Human migrations, effect on health burden of inherited disorders of hemoglobin, 333 Hyperreactive malarial splenomegaly, in sub-saharan Africa, 461 I Immune complex-mediated hemolysis, associated with severe malaria, India, hematologic disorders unique to, 243 hematological practice in, disorders of hemostasis and coagulation, inherited coagulation disorders, 436 qualitative disorders of platelets, thrombotic disorders, 436 disorders of red cells, hereditary hemochromatosis, 435 nutritional anemias, 434 other anemias, 435 thalassemias and hemoglobinopathies, 435 hematologic malignancies, acute leukemias, lymphoproliferative neoplasms, multiple myeloma, 440 myeloproliferative disorders, Infection, increased risk of, with iron supplementation, 315 Infections, estimating global burden of anemia due to, in children with sickle cell disease in sub-saharan Africa, in the tropics, hematologic changes associated with, , bartonellosis, childhood HIV, hookworm, 237, malaria, 236, clinical management of, hyperreactive malarial splenomegaly syndromes, in pregnancy, in splenectomized patients, 404 severe, schistosomiasis, 237, 407 trypanosomiasis, 237, visceral leishmaniasis (Kala-azar), 237, risks of, from transfusions in developing countries, 479 blood-borne infections, 479 other infections, 479 Inherited disorders, of hemoglobin, global burden of, awareness and recognition of global health burden, current health burden, factors affecting health burden of, future health burden,

11 523 structural hemoglobin variants, thalassemias, , red cell, in sub-saharan Africa, sickle cell disease, Iron deficiency anemia, diagnosis and prevention at the population level, epidemiology, framework for control, future directions, iron status measurement in public health context, other measures for control, anthelmintic therapy, 314 delayed cord clamping, 313 effects of supplementation on functional health outcomes, iron enrichment of cooked foods, 314 malaria control, 313 risks of iron supplementation, clinical trials data, diarrhea, infection, 315 malaria, other, 318 estimating the global burden of, in India, 434 in sub-saharan Africa, 461, 464 K Kala-azar, hematologic changes associated with, 237, L Laboratory hematology, in resource-limited settings, steps to quality improvement in, Leishmaniasis, visceral, hematologic changes associated with, 237, Leukemia, acute lymphoblastic, pediatric, global approach to, core resources in low- and middle-income countries, 423 future directions, incidence, 420 treatment and outcomes, acute myelogenous, pediatric, global approach to, 424 acute promyelocytic, in China and Hong Kong, all-trans retinoic acid for, arsenic trioxide for, acute, in India, chronic myelogenous, pediatric, global approach to, 425 geographic variability in distribution and expression of, in sub-saharan Africa, adult T-cell, chronic lymphocytic, 467 chronic myeloid, 467 Lymphoma, geographic variability in distribution and expression of,

12 524 Lymphoma (continued) Hodgkin, pediatric, global approach to, in China and Hong Kong, natural killer/t-cell, other 1 lymphoid malignancies, 451 non-hodgkin, pediatric, global approach to, Lymphoproliferative neoplasms, in India, M Malabsorption, in the tropics, hematologic aspects of, Malaria, control of, in prevention of anemia, 313 effect on health burden of inherited disorders of hemoglobin, 332 glucose-6-phosphate dehydrogenase (G6PD) deficiency and, hematologic changes associated with, 236, clinical management of, hyperreactive malarial splenomegaly syndrome, in pregnancy, in splenectomized patients, 404 life cycle of, severe, coagulation abnormalities, 403 decreased erythrocyte deformability, 400 defective marrow response, immune complex-mediated hemolysis, malarial anemia, 398 massive intravascular hemolysis, 400 role of hemolysis, 398 role of spleen, in sub-saharan Africa, anemia and, in children with sickle cell disease, increased risk of, with iron supplementation, Malignancies, hematologic, in China and Hong Kong, acute promyelocytic leukemia, different patterns of lymphomas, 449 natural killer/t-cell lymphomas, other T-cell lymphoid malignancies, 451 in India, acute leukemias, lymphoproliferative neoplasms, multiple myeloma, 440 myeloproliferative disorders, in sub-saharan Africa, adult T-cell leukemia and lymphoma, chronic lymphocytic leukemia, 467 chronic myeloid leukemia, 467 pediatric, global approach to, acute lymphoblastic leukemia, acute myelogenous leukemia, 424 capacity building through twinning, 419 chronic myelogenous leukemia, 425

13 525 Hodgkin lymphoma, non-hodgkin lymphoma, role of essential medicines, Migrations, human, effect on health burden of inherited disorders of hemoglobin, 333 Multiple myeloma, in India, 440 Myeloproliferative disorders, in India, N Natural killer/t-cell lymphomas, in China and Hong Kong, advances in, 450 epidemiology and pathology, 449 monitoring of treatment outcome, 450 prognostication of, treatment of, 450 Newborn screening, for inherited disorders of hemoglobin, 334 Nigeria, development of national transfusion service in, Non-Hodgkin lymphoma, pediatric, global approach to, Nutritional anemia, in India, 434 in sub-saharan Africa, folate deficiency, 465 iron deficiency, 464 vitamin B 12 deficiency, 465 P Pediatrics. See also Children. global approach to hematologic malignancies, acute lymphoblastic leukemia, acute myelogenous leukemia, 424 capacity building through twinning, 419 chronic myelogenous leukemia, 425 Hodgkin lymphoma, non-hodgkin lymphoma, role of essential medicines, Platelet disorders, in sub-saharan Africa, 468 vascular purpura, 468 qualitative, in India, Population stratification, effect on health burden of inherited disorders of hemoglobin, 334 Pregnancy, malaria and anemia in, in sub-saharan Africa, Public health, iron status measurement in context of, Q Quality improvement, in laboratory hematology in resource-limited settings, R Resource-limited settings, improving laboratory and clinical hematology in, Retinoic acid, all trans, for acute promyelocytic leukemia treatment in China and Hong Kong,

14 526 S Schistosomiasis, hematologic changes associated with, 237, 407 Sickle cell disease, in sub-saharan Africa, , bottlenecks in care of, causes of death in children with, bacteremia, malaria, future of, 349 future priorities for, 351 natural history of, 346 origins of sickle mutation, specific treatments in, present and future global burden, Snake bite, coagulation disorders due to, in sub-saharan Africa, 469 Soluble transferring receptor, for iron status measurement at population level, Spleen, role of, in severe malaria, Splenectomized patients, malaria in, 404 Splenomegaly, hyperactive malarial splenomegaly syndrome, hyperreactive malarial, in sub-saharan Africa, 461 Stratification, population, effect on health burden of inherited disorders of hemoglobin, 334 Sub-Saharan Africa. See Africa, sub-saharan. T T-cell lymphomas, in China and Hong Kong, natural killer cell/t-cell lymphomas, other T-cell lymphoid malignancies, 451 in sub-saharan Africa, 468 Thailand, control and management of thalassemias in, hematologic disorders unique to, 243 Thalassemias, improving laboratory and clinical hematology in resource-limited settings, in China and Hong Kong, in India, 435 present and future global burden, progress toward control and management, global issues, in other regions of Asia, in Thailand, progress toward control and management of, Thromboembolic disorders, in sub-saharan Africa, 469 Transferrin saturation, for iron status measurement at population level, Transfusion medicine, in developing countries, research directions in, See also Blood transfusions. Tropics, infections in, hematologic changes associated with, , bartonellosis, childhood HIV, hookworm, 237, malaria, 236, clinical management of,

15 527 hyperreactive malarial splenomegaly syndrome, in pregnancy, in splenectomized patients, 404 severe, schistosomiasis, 237, 407 trypanosomiasis, 237, African, American (Chagas disease), 408 visceral leishmaniasis (Kala-azar), 237, Trypanosomiasis, hematologic changes associated with, 237, African, American (Chagas disease), 408 V Vascular purpura, in sub-saharan Africa, 468 Viral hemorrhagic fevers, in the tropics, hemostatic failure in, dengue, others, 241 Vitamin B 12 deficiency, anemia due to, in sub-saharan Africa, 465 Vitamin K-dependent coagulation factors, deficiencies of, in sub-saharan Africa, 469 von Willebrand disease, in sub-saharan Africa, 470 W White blood cell disorders. See Leukemias and Lymphomas. World Health Organization (WHO), objectives for blood transfusion, 484 X X-linked genetic polymorphisms, glucose-6-phosphate dehydrogenase (G6PD) deficiency,

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam: Hematology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified hematologist

More information

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,

More information

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY 1. Module/unit Code II. 1.2. 2. Module/unit Title Hematology 3. Subject Field Internal Diseases Group 4. Faculty/Department General Medicine, Department of Hematology 5. Programme(s) to which the Doctor

More information

SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE-2. Total hours number 70 hours, including course 20 hours, seminars 50 hours.

SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE-2. Total hours number 70 hours, including course 20 hours, seminars 50 hours. SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE- Total hours number 70 hours, including course 0 hours, seminars 0 hours. Aim of the subject of Hematology: The study of etiology, pathogenesis,

More information

HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint

HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Hematology MOC exam blueprint Based on feedback from physicians that MOC assessments should

More information

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 July 3, 2013 The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Re: Physician Compare Intelligent Search To Whom it May Concern, The American

More information

Contents SECTION 1: PHYSIOLOGY OF BLOOD

Contents SECTION 1: PHYSIOLOGY OF BLOOD Contents SECTION 1: PHYSIOLOGY OF BLOOD Chapter 1: Overview of Physiology of Blood 1 Normal Haematopoiesis 1 Red Blood Cells 6 White Blood Cells 15 Immune System 27 Megakaryopoiesis 32 Normal Haemostasis

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Abdominal tumors, in children, 530 531 Alkalinization, in tumor lysis syndrome, 516 Allopurinol, in tumor lysis syndrome, 515 Anaphylaxis, drug

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Anemia(s), 412 426 categories in morphologic approach to, macrocytic, 412 414 microcytic, 412 414 normocytic, 412 413 categorizing, 412

More information

Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89

Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89 Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89 Presented by Jennifer Kurkulonis 1 FOUR MAJOR TYPES OF BLOOD CELLS White blood cells

More information

ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology

ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology ACGME approved: June 27, 2006; effective: July 1, 2007 ACGME approved focused revision: September 30, 2012; effective:

More information

SAUDI FELLOWSHIP TRAINING PROGRAM. Adult Haematology. Final Written Examination 2019

SAUDI FELLOWSHIP TRAINING PROGRAM. Adult Haematology. Final Written Examination 2019 SAUDI FELLOWSHIP TRAINING PROGRAM Adult Haematology Final Written Examination 2019 Examination Format: A. The Saudi fellowship specialty final written examination shall consist of one paper with 80-120

More information

Preferred Clinical Services for Leading Age Florida August 26-27, 2015

Preferred Clinical Services for Leading Age Florida August 26-27, 2015 DIAGNOSIS CODING ESSENTIALS FOR LONG-TERM CARE: CHAPTER 3, D CODES DISEASES OF THE BLOOD AND BLOOD-FORMING ORGANS AND CERTAIN DISORDERS INVOLVING THE IMMUNE MECHANISM Preferred Clinical Services for Leading

More information

Pediatric Hematology-Oncology

Pediatric Hematology-Oncology Pediatric Hematology-Oncology Content Outline In-Training, Initial Certification, and Maintenance of Certification Exams Effective for exams administered beginning April 1, 2019 THE AMERICAN BOARD of PEDIATRICS

More information

QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS

QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS WHAT IS TRUE AND WHAT IS FALSE? Questions 1 Iron deficiency anemia a) Is usually associated with a raised MCV. b) The MCH is usually low. c) Is most commonly due

More information

Saudi Fellowship Training Program. Final Written Examination of Adult Hematology 2018

Saudi Fellowship Training Program. Final Written Examination of Adult Hematology 2018 Saudi Fellowship Training Program Final Written Examination of Adult Hematology 2018 Objectives: Determine the quantity and quality of a hematologist s knowledge base ranked as competent, so that the individual

More information

The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011)

The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011) The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011) By Gene Gulati, Ph.D., SH(ASCP) Conflict of Interest None Plan for the Course Review blood smears,

More information

Disorders of Blood Cells & Blood Coagulation

Disorders of Blood Cells & Blood Coagulation Disorders of Blood Cells & Blood Coagulation HIHIM 409 WBC count RBC count WBC differential Hemoglobin (HGB) Hematocrit (HCT) % of volume occupied by RBCs CBC Red cell indices Mean cell volume (MCV) average

More information

Blood Transfusion Guidelines in Clinical Practice

Blood Transfusion Guidelines in Clinical Practice Blood Transfusion Guidelines in Clinical Practice Salwa Hindawi Director of Blood Transfusion Services Associate Professor in Haematology and Transfusion Medicine King Abdalaziz University, Jeddah Saudi

More information

Recommended Timing for Transplant Consultation

Recommended Timing for Transplant Consultation REFERRAL GUIDELINES Recommended Timing for Transplant Consultation Published jointly by the National Marrow Donor Program /Be The Match and the American Society for Blood and Marrow Transplantation BeTheMatchClinical.org

More information

a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation

a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation This resource has been developed to help guide you regarding the appropriate timing and conditions for a referral

More information

Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology

Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology Faculty representative: Neil Weiner, MD Resident representative: Guiherme Rabinowits, MD Revision date: February 28, 2006 Goals

More information

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA Introduction: GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS These guidelines have been developed in conjunction with the hospital Transfusion Committee.

More information

ASPHO 2019 Review Course January 31-February 2, 2019

ASPHO 2019 Review Course January 31-February 2, 2019 ASPHO 2019 Review Course January 31-February 2, 2019 ABP Content Outline Topics by Date and Speaker For additional information, see the ABP Content Outline and the ABP Content Outline with Speaker Assignments.

More information

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi Anemia (3).ms4.25.Oct.15 Hemolytic Anemia Abdallah Abbadi Case 3 24 yr old female presented with anemia syndrome and jaundice. She was found to have splenomegaly. Hb 8, wbc 12k, Plt 212k, retics 12%, LDH

More information

Extra Notes 3. Warm. In the core (center) of the body, where the temperature is 37 C.

Extra Notes 3. Warm. In the core (center) of the body, where the temperature is 37 C. Extra Notes 3 *The numbers of the slides are according to the last year slides. Slide 33 Autoimmune hemolytic anemia : Abnormal circulating antibodies that target normal antigen on the RBC and cause lysis.

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Abdominal radiotherapy, toxic effects of, 636 637 Acute promyelocytic leukemia, associated with acquired bleeding problems, 614 615 Acute renal

More information

Anemia (3).ms Hemolytic Anemia. Abdallah Abbadi Feras Fararjeh

Anemia (3).ms Hemolytic Anemia. Abdallah Abbadi Feras Fararjeh Anemia (3).ms4.26.2.18 Hemolytic Anemia Abdallah Abbadi Feras Fararjeh Case 3 24 yr old female presented with anemia syndrome and jaundice. She was found to have splenomegaly. Hb 8, wbc 12k, Plt 212k,

More information

Composition of Blood

Composition of Blood Composition of Blood Erythrocytes Disorders of Erythrocytes Hematocrit Leukocytes Disorders of Leukocytes Platelets Hemostasis Disorders of Clotting Blood Types Blood Transfusion Unit 7 Blood Composition

More information

Hematology Page 1 of 8

Hematology Page 1 of 8 Hematology Page 1 of 8 Hematology Major Category Code Headings Revised 12/17 1 Basic methodology and test armamentarium 20000 2 Normal hematopoiesis & hemostasis 20100 3 RBC disorders, non-neoplastic 20340

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Activated partial thromboplastin time abnormality, perioperative approach to, 104 105 Acute kidney injury, perioperative, 89 99 early

More information

Chapter 46. Care of the Patient with a Blood or Lymphatic Disorder

Chapter 46. Care of the Patient with a Blood or Lymphatic Disorder Chapter 46 Care of the Patient with a Blood or Lymphatic Disorder All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. Components of the Blood Red

More information

C. treatment with Desferal (deferoxamine mesylate USP, iron-chelating agent)

C. treatment with Desferal (deferoxamine mesylate USP, iron-chelating agent) HEMOLYTIC ANEMIAS Single choice tests 1. Select the clinical manifestation that is not characteristic for the hemolytic crisis: A. decrease of the red blood cell count B. reticulocytosis C. jaundice D.

More information

Index. Note: Page numbers of article numbers are in boldface type.

Index. Note: Page numbers of article numbers are in boldface type. Index Note: Page numbers of article numbers are in boldface type. A Abdomen, acute, as cancer emergency, 381 399 in cancer patients, etiologies unique to, 390 392 in perforation, 388 surgery of, portal

More information

Peking University People's Hospital, Peking University Institute of Hematology

Peking University People's Hospital, Peking University Institute of Hematology Qian Jiang, M.D. Peking University People's Hospital, Peking University Institute of Hematology No. 11 Xizhimen South Street, Beijing, 100044, China. Phone number: 86-10-66583802 Mobile: 86-13611115100

More information

Myeloproliferative Disorders - D Savage - 9 Jan 2002

Myeloproliferative Disorders - D Savage - 9 Jan 2002 Disease Usual phenotype acute leukemia precursor chronic leukemia low grade lymphoma myeloma differentiated Total WBC > 60 leukemoid reaction acute leukemia Blast Pro Myel Meta Band Seg Lymph 0 0 0 2

More information

Chapter 13 The Blood

Chapter 13 The Blood Chapter 13 The Blood Copyright 2015 Wolters Kluwer Health Lippincott Williams & Wilkins Overview Key Terms agglutination erythrocyte lymphocyte albumin fibrin megakaryocyte anemia hematocrit monocyte antigen

More information

HEME 10 Bleeding Disorders

HEME 10 Bleeding Disorders HEME 10 Bleeding Disorders When injury occurs, three mechanisms occur Blood vessels Primary hemostasis Secondary hemostasis Diseases of the blood vessels Platelet disorders Thrombocytopenia Functional

More information

What are the four parts of blood and what are their main functions?

What are the four parts of blood and what are their main functions? 1/24/19 Bell Ringer: Please COPY THE QUESTION in your notebook and date it below your drawing from yesterday: THEN ANSWER IT IN WRITING IN YOUR NOTEBOOK FOR POINTS. What are the four parts of blood and

More information

3/5/2013. Hematopoiesis: Red and white marrow. Hematopoiesis. Bone marrow aspirate and core biopsy. Gartner, Color Textbook of Histology, 3 rd Edition

3/5/2013. Hematopoiesis: Red and white marrow. Hematopoiesis. Bone marrow aspirate and core biopsy. Gartner, Color Textbook of Histology, 3 rd Edition Hematopoiesis Hematopoiesis: Red and white marrow Bone marrow aspirate and core biopsy Gartner, Color Textbook of Histology, 3 rd Edition 1 reticulocytes elliptocytes schistocytes spheroctyes target cells

More information

Al-Balqa Applied University Faculty of Medicine

Al-Balqa Applied University Faculty of Medicine Al-Balqa Applied University Faculty of Medicine Course Title: Blood and Lymphatic System (BLS). Course Code: 31500371 Credit Hours: 4 Credits Calendar Description: 4 weeks/ sem.2/ year 2 Teaching approaches:

More information

Examination Tests from Pathological Physiology. Pavel Maruna et al. Reviewed by: Prof. MUDr. Emanuel Nečas, DrSc. Prof. MUDr. Jaroslav Veselý, CSc.

Examination Tests from Pathological Physiology. Pavel Maruna et al. Reviewed by: Prof. MUDr. Emanuel Nečas, DrSc. Prof. MUDr. Jaroslav Veselý, CSc. Examination Tests from Pathological Physiology Pavel Maruna et al. Reviewed by: Prof. MUDr. Emanuel Nečas, DrSc. Prof. MUDr. Jaroslav Veselý, CSc. Authors: Prof. MUDr. Pavel Maruna, CSc. Doc. MUDr. Martin

More information

The American Society of Hematology (ASH) represents more than 17,000 clinicians and

The American Society of Hematology (ASH) represents more than 17,000 clinicians and American Society of Hematology Statement to the House Appropriations Subcommittee on Labor, HHS, Education, and Related Agencies FY 2020 Funding for NIH and CDC The American Society of Hematology (ASH)

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Abdomen, acute, in oncological surgery patients, critical care issues in, 101 102 Acquired factor VIII inhibitors, in critically ill cancer

More information

Theme: Making Further Advancements in the Treatment of Hematologic Diseases - Frontline therapies and future prospects -

Theme: Making Further Advancements in the Treatment of Hematologic Diseases - Frontline therapies and future prospects - Theme: Making Further Advancements in the Treatment of Hematologic Diseases - Frontline therapies and future prospects - Professor Yutaka YATOMI, M.D., Ph.D., The Department of Clinical Laboratory Medicine,

More information

(anemia) ก hemoglobin concentration, hematocrit deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2

(anemia) ก hemoglobin concentration, hematocrit deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2 ก ก. ก ก.. ก (anemia) ก hemoglobin concentration, hematocrit ก ก ก 2 Standard deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2 Hemoglobin hematocrit MCV (g/dl) (%) (fl) ( ) 0.5-1.9

More information

General Characterisctics

General Characterisctics Anemia General Characterisctics Definition: anemia is a decrease in red blood cells. Happens due to underproduction, increased destruction or loss of red cells. Diagnosis of anemia: Hgb < 135 (men) Hgb

More information

Approach to a pale child

Approach to a pale child Approach to a pale child Dr. Dafalla Ahmed Babiker Jazan university objectives Definition of anemia Classification and causes Important points in history and physical examination Investigations. Definition

More information

Normal Development. Normal Development 10/16/2012. Hematopoietic and Lymph Node Pathology. Red Blood Cell Maturation & Anemias

Normal Development. Normal Development 10/16/2012. Hematopoietic and Lymph Node Pathology. Red Blood Cell Maturation & Anemias Hematopoietic and Lymph Node Pathology Normal Development Red Blood Cell Maturation & Anemias Normal Development Differentiation of Hematopoietic Cells 1 Bone Marrow Bone Marrow Bone Marrow, RBC Precursors

More information

PCCN Review Hematology

PCCN Review Hematology PCCN Review Hematology Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC CEN, CNRN, CMSRN, NP Education Specialist LRM Consulting Nashville, TN Anemia Definition reduction in RBC concentration Causes iron deficiency

More information

Care of the Patient with a Blood or Lymphatic Disorder. ph Volume pints. Red blood cells (RBC) White blood cells (WBC)

Care of the Patient with a Blood or Lymphatic Disorder. ph Volume pints. Red blood cells (RBC) White blood cells (WBC) Slide 1 Chapter 7 Care of the Patient with a Blood or Lymphatic Disorder 1 Slide 1 Overview of Anatomy and Physiology Characteristics of blood Consistency (viscous) 45% blood cells RBC WBC Platelets 55%

More information

2013 Pathology Student

2013 Pathology Student About this guide If you re reading this introduction, it means you are probably either a) covering hematopathology in your pathology class right now, or b) studying for boards. Either way, you ve come

More information

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate

More information

Hematology. The Study of blood

Hematology. The Study of blood Hematology The Study of blood Average adult = 8-10 pints of blood Composition: PLASMA liquid portion of blood without cellular components Serum plasma after a blood clot is formed Cellular elements are

More information

Table 8.1. Epidemiology of Leukemia in the United States (2010) Annual Deaths. Mean Age. Percentage of All Leukemias (%) (Number of New Cases)

Table 8.1. Epidemiology of Leukemia in the United States (2010) Annual Deaths. Mean Age. Percentage of All Leukemias (%) (Number of New Cases) Table 8.1. Epidemiology of Leukemia in the United States (2010) Type of Leukemia Annual Incidence (Number of New Cases) Percentage of All Leukemias (%) Annual Deaths Mean Age Acute lymphocytic 5,330 12

More information

DEPARTMENT OF CLINICAL HEMATOLOGY

DEPARTMENT OF CLINICAL HEMATOLOGY DEPARTMENT OF CLINICAL HEMATOLOGY What is blood? Blood is the vital fluid of the body, which performs diverse functions from delivering oxygen to each and every cell of the body to fighting against infections

More information

Do Now pg What part of the blood causes a blood clot? 2. Could you survive without this? Why?

Do Now pg What part of the blood causes a blood clot? 2. Could you survive without this? Why? Do Now pg 95 1. What part of the blood causes a blood clot? 2. Could you survive without this? Why? What is Hemostasis? The stopping of bleeding, which is vitally important when blood vessels are damaged.

More information

Glucose-6-Phosphate Dehydrogenase

Glucose-6-Phosphate Dehydrogenase Glucose-6-Phosphate Dehydrogenase Is the major enzyme in the pentose phosphate pathway (also called the phosphogluconate pathway or the hexose monophosphate shunt) which is a metabolic pathway parallel

More information

PGY-2 ONCOLOGY RESIDENCY ROTATION DESCRIPTION

PGY-2 ONCOLOGY RESIDENCY ROTATION DESCRIPTION PGY-2 ONCOLOGY RESIDENCY ROTATION DESCRIPTION ROTATION TITLE Outpatient Adult Oncology PURPOSE The outpatient oncology service will provide the PGY-2 resident with the opportunity to further develop and

More information

LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO.

LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO. LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA 1011.02 Transfusion Criteria Version#2 Department POLICY NO. PAGE NO. Blood Bank Quality Assurance Manual

More information

78 The Power of Peripheral Blood Smears-Apparent Diagnostic Clues (Part 1) Gene Gulati PhD, SH(ASCP)

78 The Power of Peripheral Blood Smears-Apparent Diagnostic Clues (Part 1) Gene Gulati PhD, SH(ASCP) 78 The Power of Peripheral Blood Smears-Apparent Diagnostic Clues (Part 1) Gene Gulati PhD, SH(ASCP) 2011 Annual Meeting Las Vegas, NV AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 33 W. Monroe, Ste. 1600 Chicago,

More information

Diagnostic Approach to Patients with Anemia

Diagnostic Approach to Patients with Anemia J KMA Special Issue Diagnostic Approach to Patients with Anemia Seonyang Park, MD Department of Internal Medicine, Seoul National University College of Medicine E mail : seonpark@snu.ac.kr J Korean Med

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acute lung injury (ALI) transfusion-related, 363 372. See also Transfusion-related acute lung injury (TRALI) ALI. See Acute lung injury

More information

Management of anemia in CKD

Management of anemia in CKD Management of anemia in CKD Pierre Cochat, MD PhD Professor of Pediatrics Chair, Pediatrics & Pediatric Surgery Department Head, Center for Rare Renal Diseases Néphrogones Hospices Civils de Lyon & University

More information

Hematologic changes in systemic diseases. Chittima Sirijerachai

Hematologic changes in systemic diseases. Chittima Sirijerachai Hematologic changes in systemic diseases Chittima Sirijerachai Systemic diseases Infection Renal diseases Liver diseases Connective tissue diseases Malignancy Anemia of chronic disease (ACD) Chronic infections:

More information

Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009

Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009 HAEMOLYTIC ANAEMIA Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009 WHEN BY THEN Hb 9 g% transfusion

More information

رناد زكريا Dr. ahmad Dr. ahmad. P a g e 1

رناد زكريا Dr. ahmad Dr. ahmad. P a g e 1 5 رناد زكريا Dr. ahmad Dr. ahmad P a g e 1 Before we start. -This sheet was written according to section 2 s record and reviewed according to section 1 s record by Ruba Hussien with all thanks and I referred

More information

The Evaluation and Classification of Anemia

The Evaluation and Classification of Anemia Case studies and research for better care To refer a patient, call. The Evaluation and Classification of Anemia A diagnostic approach BY AMANDA BRANDOW, DO, MS Anemia is defined as hemoglobin concentration

More information

Blood Components & Indications for Transfusion. Neda Kalhor

Blood Components & Indications for Transfusion. Neda Kalhor Blood Components & Indications for Transfusion Neda Kalhor Blood products Cellular Components: Red blood cells - Leukocyte-reduced RBCs - Washed RBCs - Irradiated RBCs Platelets - Random-donor platelets

More information

Hematologic Disorders. Assistant professor of anesthesia

Hematologic Disorders. Assistant professor of anesthesia Preoperative Evaluation Hematologic Disorders Dr M.Razavi Assistant professor of anesthesia Anemia Evaluation needs to consider the extent and type of surgery, the anticipated blood loss, and the patient's

More information

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College AN APPROACH TO BLEEDING DISORDERS NORMAL HEMOSTASIS After injury, 3 processes halt bleeding Vasoconstriction

More information

4100: Cellular Therapy Essential Data Follow-Up Form

4100: Cellular Therapy Essential Data Follow-Up Form 4100: Cellular Therapy Essential Data Follow-Up Form Registry Use Only Sequence Number: Date Received: Key Fields CIBMTR Center Number: Event date: Visit: 100 day 6 months 1 year 2 years >2 years, Specify:

More information

Average adult = 8-10 pints of blood. Functions:

Average adult = 8-10 pints of blood. Functions: Average adult = 8-10 pints of blood Functions: Transports nutrients, oxygen, cellular waste products, and hormones Aids in distribution of heat Regulates acid-base balance Helps protect against infection

More information

Microcytic Hypochromic Anemia An Approach to Diagnosis

Microcytic Hypochromic Anemia An Approach to Diagnosis Microcytic Hypochromic Anemia An Approach to Diagnosis Decreased hemoglobin synthesis gives rise to microcytic hypochromic anemias. Hypochromic anemias are characterized by normal cellular proliferation

More information

SICKLE CELL DISEASE. Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH. Assistant Professor FACULTY OF MEDICINE -JAZAN

SICKLE CELL DISEASE. Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH. Assistant Professor FACULTY OF MEDICINE -JAZAN SICKLE CELL DISEASE Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN Objective: The student should be able: To identify the presentation, diagnosis,

More information

Haematology and Haematological Oncology

Haematology and Haematological Oncology Haematology and Haematological Oncology Updated on 23 Feb 2017 I) OBJECTIVES 1. To provide a broad training and in-depth experience at a level sufficient for trainees to acquire competence and professionalism

More information

Pediatrics. Pyruvate Kinase Deficiency (PKD) Symptoms and Treatment. Definition. Epidemiology of Pyruvate Kinase Deficiency.

Pediatrics. Pyruvate Kinase Deficiency (PKD) Symptoms and Treatment. Definition. Epidemiology of Pyruvate Kinase Deficiency. Pediatrics Pyruvate Kinase Deficiency (PKD) Symptoms and Treatment See online here Pyruvate kinase deficiency is an inherited metabolic disorder characterized by a deficiency in the enzyme "pyruvate kinase"

More information

Chapter 1: Certain Infectious and parasitic diseases (A00-B99)

Chapter 1: Certain Infectious and parasitic diseases (A00-B99) ICD-10-CM Part 5 Chapter 1: Certain Infectious and parasitic diseases (A00-B99) New sub-chapter: Infections with a predominantly sexual mode of transmission (A50-A64) You will not find: septicemia - rather,

More information

Wiskott-Aldrich Syndrome

Wiskott-Aldrich Syndrome chapter 7 Wiskott-Aldrich Syndrome Wiskott-Aldrich syndrome is a primary immunodeficiency disease involving both T- and B-lymphocytes. In addition, the blood cells that help control bleeding, called platelets

More information

Chapter 06 Lecture Outline. See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes.

Chapter 06 Lecture Outline. See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Chapter 06 Lecture Outline See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Copyright 2016 McGraw-Hill Education. 2012 Pearson Permission Education,

More information

Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: HEMATOLOGY Revised: 11/2013

Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: HEMATOLOGY Revised: 11/2013 Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: HEMATOLOGY Revised: 11/2013 What type of tissue is blood? Blood is considered liquid connective

More information

High Hemoglobin F in a Saudi Child Presenting with Pancytopenia

High Hemoglobin F in a Saudi Child Presenting with Pancytopenia Case Report imedpub Journals http://www.imedpub.com Journal of Pediatric Care ISSN 2471-805X DOI: 10.21767/2471-805X.100002 High Hemoglobin F in a Saudi Child Presenting with Pancytopenia Abstract Saudi

More information

Sickle Cell Disease and impact on the society

Sickle Cell Disease and impact on the society Sickle Cell Disease and impact on the society Professor Z.A.Jeremiah Ph.D, FRCPath (London) Professor of Haematology and Blood Transfusion Science Niger Delta University, Wilberforce Island Outline What

More information

5/9/2018. Bone marrow failure diseases (aplastic anemia) can be cured by providing a source of new marrow

5/9/2018. Bone marrow failure diseases (aplastic anemia) can be cured by providing a source of new marrow 5/9/2018 or Stem Cell Harvest Where we are now, and What s Coming AA MDS International Foundation Indianapolis IN Luke Akard MD May 19, 2018 Infusion Transplant Conditioning Treatment 2-7 days STEM CELL

More information

Drop of Blood Unravels Mysteries. Prof. Salma Afrose Department of Hematology Dhaka Medical College

Drop of Blood Unravels Mysteries. Prof. Salma Afrose Department of Hematology Dhaka Medical College Drop of Blood Unravels Mysteries Prof. Salma Afrose Department of Hematology Dhaka Medical College Peripheral Blood Film (PBF) PBF is a laboratory workup that involves cytology of Peripheral blood cell

More information

Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN

Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN The student should be able:» To identify the mechanism of homeostasis and the role of vessels, platelets

More information

11. An acute leukemia causing. 12. An adult patient presents with acute. 13. Anemia due to renal failure may be

11. An acute leukemia causing. 12. An adult patient presents with acute. 13. Anemia due to renal failure may be Hematology Study online at 1. A 23 year old white female has weakness, fatigue and has developed a habit of chewing ice. What are the expected findings in regard to TIBC and Ferritin? 2. A 25 year old

More information

Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017

Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017 Overview of Aplastic Anemia Overview of Aplastic Anemia Peter Westervelt, MD, PhD Professor of Medicine Chief, BMT/Leukemia Section Washington University School of Medicine Epidemiology Normal hematopoiesis

More information

CrackCast Episode 7 Blood and Blood Components

CrackCast Episode 7 Blood and Blood Components CrackCast Episode 7 Blood and Blood Components Episode Overview: 1) Describe the 3 categories of blood antigens 2) Who is the universal donor and why? 3) Define massive transfusion 4) List 5 physiologic

More information

1. Adequate diet and iron intake to prevent iron deficiency 2. Signs and symptoms of malignant disease

1. Adequate diet and iron intake to prevent iron deficiency 2. Signs and symptoms of malignant disease Hematology/Oncology Description: The pediatric hematology-oncology division sees a wide spectrum of pediatric disease including but not limited to leukemia, hemophilia, solid tumors, ITP, and other blood

More information

Miss. kamlah ahmed 1

Miss. kamlah ahmed 1 Miss. kamlah ahmed 1 Anatomy & Physiology Blood has two compartments: 1- a fluid portion called plasma. 2- a cellular portion known as the formed elements of the blood. Which are RBC (erythrocytes), WBC

More information

PATHOLOGY & PATHOPHYSIOLOGY

PATHOLOGY & PATHOPHYSIOLOGY PATHOLOGY & PATHOPHYSIOLOGY DISORDERS OF BLOOD DISORDERS OF BLOOD Disorders of Blood Infections Tumours Nutritional disorders Coagulation disorders Congenital disorders Septicaemia Leukemia Iron deficiency

More information

Putting some hematology into Pediatric Hematology/Oncology: a review of Hemophilia and Sickle Cell Disease in the Pediatric Patient

Putting some hematology into Pediatric Hematology/Oncology: a review of Hemophilia and Sickle Cell Disease in the Pediatric Patient Putting some hematology into Pediatric Hematology/Oncology: a review of Hemophilia and Sickle Cell Disease in the Pediatric Patient Kristina Haley, DO March 10, 2012 Jovita Reyes Memorial Pediatric Hematology/Oncology

More information

Careers in Haematology

Careers in Haematology Careers in Haematology A guide for medical students and junior doctors About haematology: Haematology is the medical speciality concerned with blood disorders. Your non-medical friends however will always

More information

Post Travel Fever. Dr. Eyal Leshem. Center for Geographic Medicine Sheba Medical Center Tel Hashomer, Israel

Post Travel Fever. Dr. Eyal Leshem. Center for Geographic Medicine Sheba Medical Center Tel Hashomer, Israel Post Travel Fever Dr. Eyal Leshem Center for Geographic Medicine Sheba Medical Center Tel Hashomer, Israel Introduction Fever in returned traveler: Trivial vs. life threatening infections Tropical and

More information

Blood Cancers. Blood Cells. Blood Cancers: Progress and Promise. Bone Marrow and Blood. Lymph Nodes and Spleen

Blood Cancers. Blood Cells. Blood Cancers: Progress and Promise. Bone Marrow and Blood. Lymph Nodes and Spleen Blood Cancers: Progress and Promise Mike Barnett & Khaled Ramadan Division of Hematology Department of Medicine Providence Health Care & UBC Blood Cancers Significant health problem Arise from normal cells

More information

HEMATOLOGY MODULE STUDY GUIDE Course Title Hematology Module B Course Coordinator: Dr. Irfan Ashraf

HEMATOLOGY MODULE STUDY GUIDE Course Title Hematology Module B Course Coordinator: Dr. Irfan Ashraf HEMATOLOGY MODULE STUDY GUIDE A Course Title Hematology Module B Course Coordinator: Dr. Irfan Ashraf C Course Committee Dr. Irfan Ashraf, Dr. Syeda Zarreen Raza, Dr. Rubia Kashif D Objectives of Study

More information

BONE MARROW EXAMINATION FINDINGS AT AGA KHAN UNIVERSITY HOSPITAL, NAIROBI

BONE MARROW EXAMINATION FINDINGS AT AGA KHAN UNIVERSITY HOSPITAL, NAIROBI 4 EAST AFRICAN MEDICAL JOURNAL January 2010 East African Medical Journal Vol. 87 No. 1 January 2010 BONE MARROW EXAMINATION FINDINGS AT AGA KHAN UNIVERSITY HOSPITAL, NAIROBI N.A. Okinda, MBChB, MMed, Clinical

More information